Signal Transduction Associated with Hyaluronan

Chemistry and Biology of Hyaluronan

Volumn , Issue , 2004, Pages 153-188

  Day, Regina M ^a   Mascarenhas, Marcella M ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BACTERIOPHAGES; CELL CULTURE; CELL GROWTH; CELLS; CHEMICAL ACTIVATION; ENZYME ACTIVITY; GROWTH KINETICS; HYALURONIC ACID; SIGNAL TRANSDUCTION;

CELLULAR MIGRATION; CYTOPLASMIC TYROSINE KINASE; FOCAL ADHESION KINASE; GTP-BINDING PROTEINS; MITOGEN ACTIVATED PROTEIN KINASE; MURINE FIBROBLASTS; SIGNALING MOLECULES; TYROSINE-KINASE RECEPTORS;

CELL SIGNALING;

EID: 21544469761     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008044382-9/50038-8     Document Type: Chapter

References (226)

1. Weigel PH, Fuller GM, LeBoeuf RD A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986, 119:219-234.
2. Tammi M, Day AJ, Turley EA Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002, 277:4581-4584.
3. Toole BP Hyaluronan in morphogenesis. J Intern Med 1997, 242:35-40.
4. Gakunga P, Frost G, Shuster S, Cunha G, Formby B, Stern R Hyaluronan is a prerequisite for ductal branching morphogenesis. Development 1997, 124:3987-3997.
5. Laurent TC, Fraser JR Hyaluronan. FASEB J 1992, 6:2397-2404.
6. Ohkawara Y, Tamura G, Iwasaki T, Tanaka A, Kikuchi T, Shirato K Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol 2000, 23:444-451.
7. Ponta H, Sherman L, Herrlich PA CD44: from adhesion molecules to signalling regulators. Nat Mol Cell Biol 2003, 4:33-45.
8. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, Ledger P Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Investig Dermatol 1994, 103:576-579.
9. West DC, Hampson IN, Arnold F, Kumar S Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
10. Deed R, Rooney P, Kumar P, Norton JD, Smith J, Freemont AJ, Kumar S Earlyresponse gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 1997, 71:251-256.
11. Rahmanian M, Pertoft H, Kanda S, Christofferson R, Claesson-Welsh L, Helden P Hyaluronan oligosaccharides induce tube formation of a brain endotelial cell line in vitro. Exp Cell Res 1997, 237:223-230.
12. Meyers SA Equine sperm-oocyte interaction: the role of sperm surface hyaluronidase. Anim Reprod Sci 2001, 68:291-303.
13. Rutllant J, Meyers SA Posttranslational processing of PH-20 during epididymal sperm maturation in the horse. Biol Reprod 2001, 65:1324-1331.
14. Chajara A, Levesque H, Courel MN, Chauzy C, Maingonnat C, Bertrand P, Delpech B Hyaluronan and hyaluronectin production in injured rat thoracic aorta. Atherosclerosis 1996, 125:193-207.
15. Meyers SA, Seaber AV, Glisson RR, Nunley JA Effect of hyaluronic acid/chondroitin sulfate on healing of full-thickness tendon lacerations in rabbits. J Orthop Res 1989, 7:683-689.
16. Chen W, Abatangelo G Functions of hyaluronan in wound repair. Wound Repair Regen 1999, 7:79-89.
17. Burd DAR, Greco RM, Regauer S, Longaker MT, Siebert JW, Garg HG Hyaluronan and wound healing: a new perspective. Br J Plast Surg 1991, 44:579-584.
18. Scott JE Extracellular matrix, supramolecular organisation and shape. J Anat 1995, 187:259-269.
19. Ward JA, Huang L, Guo H, Ghatak S, Toole BP Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol 2003, 162:1403-1409.
20. Yasuda M, Nakano K, Yasumoto K, Tanaka Y CD44: functional relevance to inflammation and malignancy. Histol Histopathol 2002, 17:945-950.
21. West DC, Kumar S Tumour-associated hyaluronan: a potential regulator of tumour angiogenesis. Int J Radiat Biol 1991, 60:55-60.
22. Bourguignon LY, Singleton PA, Zhu H, Zhou B Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem 2002, 277:39703-39712.
23. Csoka T, Frost G, Stern R Hyaluronidase in tissue invasion. Invasion Metastasis 1997, 17:297-311.
24. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A Hyaluronan: fundamental principles and applications in cancer. J Intern Med 1997, 242:41-48.
25. Rooney P, Kumar S, Ponting J, Wang M The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995, 60:632-636.
26. Mascarenhas MM, Day RM, Ochoa CD, Choi WI, Yu L, Ouyang B, Garg HG, Hales CA, Quinn DA Low molecular weight hyaluronan from stretched lung enhances IL-8 expression. Am J Respir Cell Mol Biol 2004, 30:51-60.
27. Turino GM, Cantor JO Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med 2003, 167:1169-1175.
28. Horton MR, Olman MA, Noble PW Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury. Chest 1999, 116:17S.
29. Svee K, White J, Vaillant P, Jessurun J, Roongta U, Krumwiede M, Johnson D, Henke C Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Investig 1996, 98:1713-1727.
30. Rothenberg M CD44-a sticky target for asthma. J Clin Investig 2003, 111:1460-1462.
31. Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A Hyaluronan in inflammatory joint disease. Acta Orthop Scand Suppl 1995, 266:116-120.
32. Laurent TC, Laurent UB, Fraser JR Serum hyaluronan as a disease marker. Ann Med 1996, 28:241-253.
33. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 1996, 66:664-668.
34. West DC, Kumar S Hyaluronan and angiogenesis. Ciba Found Symp 1989, 143:187-201.
35. West DC, Kumar S The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989, 183:179-196.
36. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001, 276:19420-19430.
37. Moffat FL, Han T, Li ZM, Peck MD, Falk RE, Spalding PB, Jy W, Ahn YS, Chu AJ, Bourguignon LY Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol 1996, 168:638-647.
38. Lesley J, Hascall VC, Tammi M, Hyman R Hyaluronan binding by cell surface CD44. J Biol Chem 2000, 275:26967-26975.
39. Aruffo A CD44: one ligand, two functions. J Clin Investig 1996, 98:2191-2192.
40. Abattangelo G, Weigel P New Frontiers in Medical Sciences: Redefining Hyaluronan 2000, Elsevier, Amsterdam.
41. Knudson C, Knudson W Hyaluronan binding proteins in development, tissue homeostasis and disease. FASEB J 1993, 7:1233-1241.
42. Toole BP Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990, 2:839-844.
43. Slevin M, Kumar S, Gaffney J Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002, 277:41046-41059.
44. Vincent T, Jourdan M, Sy MS, Klein B, Mechti N Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein. J Biol Chem 2001, 276:14728-14736.
45. Jiang H, Peterson RS, Wang W, Bartnik E, Knudson CB, Knudson W A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J Biol Chem 2002, 277:10531-10538.
46. Sugiyama K, Komada Y, Deguchi T, Zhang XL, Azuma E, Ido M, Yamamoto H, Sakurai M CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region. Immunol Investig 1999, 28:185-200.
47. Rafi A, Nagarkatti M, Nagarkatti PS Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 1997, 89:2901-2908.
48. Ishida O, Tanaka Y, Morimoto I, Takigawa M, Eto S Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 1997, 12:1657-1663.
49. Bourguignon GJ, Iida N, Welsh CF, Zhu D, Kongrad A, Pasquale D Involvement of CD44 and its variant isoforms in membrane-cytoskeletal interactions, cell adhesion and tumor metastasis. J Neurooncol 1995, 26:201-208.
50. Bourguignon LY, Zhu H, Shao L, Chen YW CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 2000, 275:1829-1838.
51. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW Resolution of lung inflammation by CD44. Science 2002, 296:155-158.
52. van der Voort R, Manten-Horst E, Smit L, Ostermann E, van den Berg F, Pals ST Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem Biophys Res Commun 1995, 214:137-144.
53. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002, 16:3074-3086.
54. Day AJ, Prestwich GD Hyaluronan-binding proteins: tying up the giant. J Biol Chem 2002, 277:4585-4588.
55. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Investig 1996, 98:2403-2413.
56. Miyake K., Underhill CB, Lesley J, Kincade PW Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990, 172:69-75.
57. Turley EA, Noble PW, Bourguignon LY Signaling properties of hyaluronan receptors. J Biol Chem 2002, 277:4589-4592.
58. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001, 15:968-980.
59. Lesley J, Kincade PW, Hyman R Antibody-induced activation of the hyaluronan receptor function of CD4 requires multivalent binding by antibody. Eur J Immunol 1993, 23:1902-1909.
60. Lesley J, Hyman R, Kincade PW CD44 and its interaction with extracellular matrix. Adv Immunol 1993, 54:271-335.
61. Lesley J, English NM, Gal I, Mikecz K, Day AJ, Hyman R Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6. J Biol Chem 2002, 277:26600-26608.
62. Gal I, Lesley J, Ko W, Gonda A, Stoop R, Hyman R, Mikecz K Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow. J Biol Chem 2003, 278:11150-11158.
63. Perschl A, Lesley J, English N, Trowbridge I, Hyman R Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 1995, 25:495-501.
64. Lokeshwar VB, Fregien N, Bourguignon LY Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 1994, 126:1099-1109.
65. Liu D, Sy MS A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J Exp Med 1996, 183:1987-1994.
66. Liu D, Liu T, Sy MS Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid. Cell Immunol 1998, 190:132-140.
67. Liu D, Zhang D, Mori H, Sy MS Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain. Cell Immunol 1996, 174:73-83.
68. Liu D, Liu T., Li R, Sy MS Mechanisms regulating the binding activity of CD44 to hyaluronic acid. Front Biosci 1998, 3:D631-D636.
69. Pure E, Camp RL, Peritt D, Panettieri RA, Lazaar AL, Nayak S Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 1995, 181:55-62.
70. Bates RC, Edwards NS, Burns GF, Fisher DE A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 2001, 61:5275-5283.
71. Fitzgerald KA, Bowie AG, Skeffington BS, O'Neill LA Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J Immunol 2000, 164:2053-2063.
72. Fujita Y, Kitagawa M, Nakamura S, Azuma K, Ishii G, Higashi M, Kishi H, Hiwasa T, Koda K, Nakajima N, Harigaya K CD44 signaling through focal adhesion kinase and its anti-apoptotic effects. FEBS Lett 2002, 528:101-108.
73. Ranuncolo SM, Ladeda V, Gorostidy S, Morandi A, Varela M, Lastiri J, Loria D, Del Aguila R, Joffe EB, Pallotta G, Puricelli L Expression of CD44s and CD44 splice variants in human melanoma. Oncol Rep 2002, 9:51-56.
74. Lokeshwar VB, Iida N, Bourguignon LY The cell adhesion molecule, GP 116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem 1996, 271:23853-23864.
75. Hunter T Oncoprotein networks. Cell 1997, 88:333-346.
76. Neri LM, Borgatti P, Capitani S, Martelli AM The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 2002, 1584:73-80.
77. Parsons JT Focal adhesion kinase: the first ten years. J Cell Sci 2003, 116:1409-1416.
78. Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene 1999, 18:3399-3406.
79. Madrid L, Baldwin A Regulation of NF-kappaB by oncoproteins and tumor suppressor proteins. Methods Mol Biol 2003, 223:523-532.
80. Bourguignon LY, Singleton PA, Diedrich F, Zhu H Hyaluronan-mediated CD44 interaction with RhoGEF and Rho-kinase promotes Gab-1 phosphorylation and PI3 kinase signaling leading to cytokine (M-CSF) production breast tumor progression. J Biol Chem 2003, 14:14.
81. Skubitz KM, Campbell KD, Skubitz AP Tyrosine kinase activity is associated with CD44 in human neutrophils. FEBS Lett 1998, 439:97-100.
82. Rozsnyay Z Signaling complex formation of CD44 with src-related kinases. Immunol Lett 1999, 68:101-108.
83. Bourguignon LYW, Zhu D, Zhu H CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci 1998, 3:D637-D649.
84. Su W, Sin M, Darrown A, Sherman LS Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression. Glia 2003, 42:350-358.
85. Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003, 169:1122-1133.
86. Bretscher A, Reczek D, Berryman M Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 1997, 110:3011-3018.
87. Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 1993, 151:6634-6644.
88. Welsh CF, Zhu D, Bourguignon LY Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J Cell Physiol 1995, 164:605-612.
89. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rhodependent signaling pathway. J Cell Biol 1996, 135:37-51.
90. Bretscher A Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr Opin Cell Biol 1999, 11:109-116.
91. Bennett V Ankyrins. Adaptors between diverse plasma membrane proteins and the cytoplasm. J Biol Chem 1992, 267:8703-8706.
92. Luna EJ, Hitt AL Cytoskeleton-plasma membrane interactions. Science 1992, 258:955-964.
93. Zhu D, Bourguignon LY Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian, tumor cell migration. J Cell Physiol 2000, 183:182-195.
94. Zhu D, Bourguignon LY The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskeleton 1998, 39:209-222.
95. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999, 43:269-287.
96. 2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton 2002, 53:293-316.
97. Bourguignon LY, Zhu H, Shao L, Chen YW CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J. Biol Chem 2001, 276:7327-7336.
98. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H, Hamaguchi M Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 2001, 12:1859-1868.
99. Ilangumaran S, Briol A, Hoessli DC CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood 1998, 91:3901-3908.
100. Li R, Wong N, Jabali MD, Johnson P CD44-initiated cell spreading induces Pyk2 phosphorylation, is mediated by Src family kinases, and is negatively regulated by CD45. J Biol Chem 2001, 276:28767-28773.
101. Ilangumaran S, Borisch B, Hoessli DC Signal transduction via CD44: role of plasma membrane microdomains. Leuk Lymphoma 1999, 35:455-469.
102. van der Voort R, Taher TE, Wielenga VJ, Spaargaren M, Prevo R, Smit L, David G, Hartmann G, Gherardi E, Pals ST Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 1999, 274:6499-6506.
103. Sherman LS, Rizvi TA, Karyala S, Ratner N CD44 enhances neuregulin signaling by Schwann cells. J Cell Biol 2000, 150:1071-1084.
104. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem 1997, 272:27913-27918.
105. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate matebolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997, 11:996-1007.
106. Sherman L, Wainwright D, Ponta H, Herrlich P A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 1998, 12:1058-1071.
107. Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 1996, 271:2863-2867.
108. Rubin JS, Bottaro DP, Aaronson SA Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1993, 1155:357-371.
109. Jeffers M, Rong S, Vande Woude GF Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 1996, 16:1115-1125.
110. Jeffers M, Rong S, Anver M, Vande Woude GF Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene 1996, 13:853-856.
111. Jeffers M, Rao MS, Rulong S, Reddy JK, Subbarao V, Hudson E, Vande Woude GF, Resau JH Hepatocyte growth factor/scatter factor-Met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells. Cell Growth Differ 1996, 7:1805-1813.
112. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991, 10:2867-2878.
113. Komada M, Miyazawa K, Ishii T, Kitamura N Characterization of hepatocyte-growth-factor receptors on Meth A cells. Eur J Biochem 1992, 204:857-864.
114. Arakaki N, Hirono S, Ishii T, Kimoto M, Kawakami S, Nakayama H, Tsubouchi H, Hishida T, Daikuhara Y Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture. J Biol Chem 1992, 267:7101-7107.
115. Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene 2002, 21:2201-2211.
116. Schwall RH, Chang LY, Godowski PJ, Kahn DW, Hillan KJ, Bauer KD, Zioncheck TF Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol 1996, 133:709-718.
117. Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem 1997, 272:9457-9463.
118. Gunthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K Are CD44 variant isoforms involved in human tumour progression?. Cancer Surv 1995, 24:19-42.
119. Rudy W, Hofmann M, Schwartz-Albiez R, Zoller M, Heider KH, Ponta H, Herrlich P The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 1993, 53:1262-1268.
120. Olayioye MA, Neve RM, Lane HA, Hynes NE The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000, 19:3159-3167.
121. Suzuki M, Raab G, Moses MA, Fernandez CA, Klagsbrun M Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem 1997, 272:31730-31737.
122. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 1998, 17:7260-7272.
123. Yu WH, Woessner JF, McNeish JD, Stamenkovic I CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002, 16:307-323.
124. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem 2001, 276:48679-48692.
125. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992, 117:1343-1350.
126. Lokeshwar VB, Selzer MG Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 2000, 275:27641-27649.
127. Dowthwaite GP, Edwards JC, Pitsillides AA An essential role for the interaction between hyaluronan and hyaluronan binding proteins during joint development. J Histochem Cytochem 1998, 46:641-651.
128. Hall CL, Turley EA Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol 1995, 26:221-229.
129. Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med 1996, 183:1663-1668.
130. Hall CL, Lange LA, Prober DA, Turley EA pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM. Oncogene 1996, 13:2213-2224.
131. Entwistle J, Zhang S, Yang B, Wong C, Li Q, Hall CL, Day AJ, Mowat M, Greenberg AH, Turley EA Characterization of the murine gene encoding the hyaluronan receptor RHAMM. Gene 1995, 163:233-238.
132. Sherman L, Sleeman J, Herrlich P, Ponta H Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994, 6:726-733.
133. Zhang S, Chang MC, Zylka D, Turley S, Harrison R, Turley EA The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem 1998, 273:11342-11348.
134. Lynn BD, Turley EA, Nagy JI Subcellular distribution, calmodulin interaction, and mitochondrial association of the hyaluronan-binding protein RHAMM in rat brain. J Neurosci Res 2001, 65:6-16.
135. Assmann V, Jenkinson D, Marshall JF, Hart IR The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J Cell Sci 1999, 112:3943-3954.
136. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 1998, 111:1685-1694.
137. Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol Biol Cell 2003, 14:2262-2276.
138. Yang B, Zhang L, Turley EA Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 1993, 268:8617-8623.
139. Yang B, Yang BL, Savani RC, Turley EA Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 1994, 13:286-296.
140. Turley EA, Belch AJ, Poppema S, Pilarski LM Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 1993, 81:446-453.
141. Pilarski LM, Pruski E, Wizniak J, Paine D, Seeberger K, Mant MJ, Brown CB, Belch AR Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Blood 1999, 93:2918-2927.
142. Turley EA Hyaluronan and cell locomotion. Cancer Metastasis Rev 1992, 11:21-30.
143. Kornovski BS, McCoshen J, Kredentser J, Turley E The regulation of sperm motility by a novel hyaluronan receptor. Fertil Steril 1994, 61:935-940.
144. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001, 276:36770-36778.
145. Rein DT, Roehrig K, Schondorf T, Lazar A, Fleisch M, Niederacher D, Bender HG, Dall P Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis. J Cancer Res Clin Oncol 2003, 129:161-164.
146. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krahn G, Heilmann V, Gschwend J, Bergmann L, Dohner H, Schmitt M Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol 2002, 30:1029-1035.
147. Crainie M, Belch AR, Mant MJ, Pilarski LM Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood 1999, 93:1684-1696.
148. Kong QY, Liu J, Chen XY, Wang XW, Sun Y, Li H Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. Oncol Rep 2003, 10:51-55.
149. Turley EA, Austen L, Moore D, Hoare K Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res 1993, 207:277-282.
150. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 1996, 87:1891-1899.
151. Pilarski LM, Miszta H, Turley EA Regulated expression of a receptor for hyaluronan-mediated motitity on human thymocytes and T cells. J Immunol 1993, 150:4292-4302.
152. Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 1993, 123:749-758.
153. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Investig 1995, 95:1158-1168.
154. Hall CL, Wang C, Lange LA, Turley EA Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994, 126:575-588.
155. Turner CE Paxillin and focal adhesion signalling. Rev Nat Cell Biol 2000, 2:E231-E236.
156. Gares SL, Pilarski LM Balancing thymocyte adhesion and motility: a functional linkage between betal integrins and the motility receptor RHAMM. Dev Immunol 2000, 7:209-225.
157. Anneren C., Lindholm CK, Kriz V, Welsh M The FRK/RAK-SHB signaling cascade: a versatile signal-transduction patwhay that regulates cell survival, differentiation and proliferation. Rev Curr Mol Med 2003, 3:313-324.
158. Brech M, Mayer U, Schlosser E, Prehm P Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986, 239:445-450.
159. Lynn BD, Li X, Cattini PA, Nagy JI Sequence, protein expression and extracellular-regulated kinase association of the hyaladherin RHAMM (receptor for hyaluronan mediated motility) in PC12 cells. Neurosci Lett 2001, 306:49-52.
160. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci 1998, 95:588-593.
161. Rescigno M, Granucci F, Ricciardi-Castagnoli P Molecular events of bacterial-induced maturation of dendritic cells. J Clin Immunol 2000, 20:161-166.
162. Poltorak A, He X, Smirnova I, Liu MY, van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B Defective LPS signaling in C3H/HeJ and c57BL/10ScCr mice: mutations in TLR4 gene. Science 1998, 282:2085-2088.
163. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram positive bacterial cell wall components. Immunity 1999, 11:443-451.
164. Beutler B TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002, 270:109-120.
165. Bocker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U, Herweck F, Rossol S, Singer MV Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis 2003, 18:25-32.
166. Chen LY, Zuraw BL, Zhao M, Liu FT, Huang S, Pan ZK Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes. Am J Physiol Lung Cell Mol Physiol 2003, 284:L607-L613.
167. Miyake K, Nagai Y, Akashi S, Nagafuku M, Ogata M, Kosugi A Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution. J Endotoxin Res 2002, 8:449-452.
168. Ronni T, Agarwal V, Haykinson M, Haberland ME, Cheng G, Smale ST Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets. Mol Cell Biol 2003, 23:2543-2555.
169. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000, 165:1863-1870.
170. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37:1043-1055.
171. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999, 189:1777-1782.
172. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002, 3:667-672.
173. Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, Wietek C, Walch E, Wirth T, O'Neill LA Bruton's tyrosine kinase is a Toll/inteleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem 2003, 27:26258-26264.
174. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000, 12:113-117.
175. Medzhitov R, Preston-Hurlburt P, Kopp E, Stalden A, Chen C, Ghosh S, Janeway CAJ Myd88 is an adaptor protein in the hToll/IL1 receptor family signaling pathways. Mol Cell 1998, 2:253-258.
176. Heine H, El-Samalouti VT, Notzel C, Pfeiffer A, Lentschat A, Kusumoto S, Schmitz G, Hamann L, Ulmer AJ CD55/decay accelerating factor is part of the lipopoly saccharide-induced receptor complex. Eur J Immunol 2003, 33:1399-1408.
177. Akira S, Hoshino K Myeloid differentiation factor 88-dependent and-independent pathways in toll-like receptor signaling. J Infect Dis 2003, 187:S356-S363.
178. Zhang H, Tay P, Cao W, Li W, Lu J Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett 2002, 532:171-176.
179. Vogel SN, Fenton M Toll-like receptor 4 signalling: new perspectives on a complex signal-transduction problem. Biochem Soc Trans 2003, 31:664-668.
180. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169:6668-6672.
181. O'Reilly SM, Moynagh PN Regulation of Toll-like receptor 4 signalling by A20 zinc finger protein. Biochem Biophys Res Commun 2003, 303:586-593.
182. Borowsky ML, Hynes RO Layilin, a novel talin-binding transmembrane protein homologus with C-type lectins, is localized in membrane ruffles. J Cell Biol 1998, 143:429-442.
183. Bono P, Rubin K, Higgins JM, Hynes RO Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell 2001, 12:891-900.
184. Hemmings L, Rees DJ, Ohanian V, Bolton SJ, Gilmore AP, Patel B, Priddle H, Trevithick JE, Hynes RO, Critchley DR Talin contains three actin-binding sites each of which is adjacent to vinculin-binding site. J Cell Sci 1996, 109:2715-2726.
185. Bolton SJ, Barry ST, Mosley H, Jockusch BM, Wilkinson JM, Critchley DR Monoclonal antibodies recognizing the N-and C-terminal of talin disrupt actin stress fibers when microinjected into human fibroblasts. Cytoskeleton 1997, 36:363-376.
186. Lathrop WF, Carmichael EP, Myles DG, Primakoff P cDNA cloning reveals the molecular structure of a sperm surface protein, PH-20, involved in sperm-egg adhesion and the wide distribution of its gene among mammals. J Cell Biol 1990, 111:2939-2949.
187. Gmachl M, Sagan S, Ketter S, Kreil G The human sperm protein PH-20 has hyalronidase activity. FEBS Lett 1993, 336:545-548.
188. Cherr GN, Yudin AI, Overstreet JW The dual functions of GPI-anchored PH-20 hyaluronidase and intracellular signaling. Matrix Biol 2001, 20:515-525.
189. Ohno S, Ijuin C, Doi T, Yoneno K, Tanne K Expression and activity of hyaluronidase in human periodontal ligament fibroblasts. J Periodontol 2002, 73:1331-1337.
190. Beech DJ, Madan AK, Deng N Expression of PH-20 in normal and neoplastic breast tissue. J Surg Res 2002, 103:203-207.
191. Zhang H, Martin-Deleon PA Mouse epididymal Spam 1 (PH-20) is released in the luminal fluid with its lipid anchor. J Androl 2003, 24:51-58.
192. Godin DA, Fitzpatrick PC, Scandurro AB, Belafsky PC, Woodworth BA, Amedee RG, Beech DJ, Beckman BS PH20: a novel tumor marker for laryngeal cancer. Arch Otolaryngol Head Neck Surg 2000, 126:402-404.
193. Zheng Y, Deng X, Martin-Deleon PA Lack of sharing of Spam1 (Ph-20) among mouse spermatids and transmission ratio distortion. Biol Repord 2001, 64:1730-1738.
194. Baba D, Kashiwabara S, Honda A, Yamagata K, Wu Q, Ikawa M, Okabe M, Baba T Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. J Biol Chem 2002, 277:30310-30314.
195. Vines CA, Li MW, Deng X, Yudin AI, Cherr GN, Overstreet JW Identification of a hyaluronic acid (HA) binding domain in the PH-20 protein that may function in cell signalling. Mol Repord Dev 2001, 60:542-552.
196. Laurent UB, Fraser JR, Laurent TC An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp Eye Res 1988, 46:49-58.
197. Lebel L, Fraser JR, Kimpton WS, Gabrielsson J, Gerdin B, Laurent TC A pharmacokinetic model of intravenously administered hyaluronan in sheep. Pharm Res 1989, 6:677-682.
198. Frost SJ, McGary CT, Raja RH, Weigel PH Specific intracellular hyaluronic acid binding to isolated rat hepatocytes is membrane-associated. Biochim Biophys Acta 1988, 946:66-74.
199. Allen SJ, Fraser RE, Laurent UB, Reed RK, Laurent TC Turnover of hyaluronan in the rabbit pleural space. J Appl Physiol 1992, 73:1457-1460.
200. Philipson LH, Schwartz NB Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J Biol Chem 1984, 259:5017-5023.
201. Prehm P Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem J 1983, 211:191-198.
202. Scott LJ, Merrilees MJ Stimulation of smooth muscle cell glycosaminoglycan synthesis by cultured endothelial cells is dependent on endothelial cell density. Atherosclerosis 1987, 63:145-152.
203. Honda A, Noguchi N, Takehara H, Ohashi Y, Asuwa N, Mori Y Cooperative enhancement of hyaluronic acid synthesis by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity. J Cell Sci 1991, 98:91-98.
204. Suzuki M, Asplund T, Yamashita H, Heldin CH, Heldin P Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J 1995, 307:817-821.
205. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988, 256:153-158.
206. Fraser JR, Laurent TC Turnover and metabolism of hyaluronan. Ciba Found Symp 1989, 143:41-53.
207. Raja RH, McGary CT, Weigel PH Affinity and distribution of surface and intracellular hyaluronic acid receptors in isolated rat liver endothelial cells. J Biol Chem 1988, 263:16661-16668.
208. Reed RK, Laurent UB, Fraser JR, Laurent TC Removal rate of [3H]hyaluronan injected subcutaneously in rabbits. Am J Physiol 1990, 259:H532-H535.
209. Tengblad A, Laurent UB, Lilja K, Cahill RN, Engstrom-Laurent A, Fraser JR, Hansson HE, Laurent TC Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J 1986, 236:521-525.
210. Csoka AB, Frost GI, Stern R The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 2001, 20:499-508.
211. Roden L, Campbell P, Fraser JR, Laurent TC, Pertoft H, Thompson JN Enzymic pathways of hyaluronan catabolism. Ciba Found Symp 1989, 143:60-76.
212. Banerji S, Ni J, Wang S LYVE-1 a new homologue of the CD44 glycoprotein is a lymph specific receptor for hyaluronan. J Cell Biol 1999, 144:789-801.
213. Carreira CM, Nasser SM, di Tomaso E LYVE-1 is not restricted to the lymph vessels; expression for normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 2001, 61:8079-8084.
214. Zhou B, Oka JA, Singh A, Weigel PH Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J Biol Chem 1999, 274:33831-33834.
215. Zhou B, Weigel JA, Fauss L, Weigel PH Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 2000, 275:37733-37741.
216. Weigel JA, Raymond RC, Weigel PH The hyaluronan receptor for endocytosis (HARE) is not CD44 or CD54 (ICAM-1). Biochem Biophys Res Commun 2002, 294:918-922.
217. Zhou B, Weigel JA, Saxena A, Weigel PH Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis. Mol Biol Cell 2002, 13:2853-2868.
218. Wang WC, Zinn K, Bjorkman PJ Expression and structural studies of fasciclin I, an insect cell adhesion molecule. J Biol Chem 1993, 268:1448-1455.
219. Yannariello-Brown J, Frost SJ, Weigel PH Identification of the Ca(2+)-independent endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells using a photoaffinity cross-linking reagent. J Biol Chem 1992, 267:20451-20456.
220. Yannariello-Brown J, Zhou B, Ritchie D, Oka JA, Weigel PH A novel ligand blot assay detects different hyaluronan-binding proteins in rat liver hepatocytes and sinusoidal endothelial cells. Biochem Biophys Res Commun 1996, 218:314-319.
221. Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 2003, 278:9808-9812.
222. Yannariello-Brown J, McGary CT, Weigel PH The endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells is Ca(+2)-independent and distinct from a Ca(+2)-dependent hyaluronan binding activity. J Cell. Biochem 1992, 48:73-80.
223. Smedsrod B, Malmgren M, Ericsson J, Laurent TC Morphological studies on endocytosis of chondroitin sulphate proteoglycan by rat liver endothelial cells. Cell Tissue Res 1988, 253:39-45.
224. McGary CT, Raja RH, Weigel PH Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J 1989, 257:875-884.
225. Higgins MK, McMahon HT Snap-shots of clathrin-mediated endocytosis. Trends Biochem Sci 2002, 27:257-263.
226. Fraser JR, Pertoft H, Alston-Smith J, Laurent TC Uptake of hyaluronan in hepatic endothelial cells is not directly affected by endotoxin and associated cytokines. Exp Cell Res 1991, 197:8-11.